XML 18 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 263,180 $ 316,827
Marketable securities, at fair value 174,809 198,563
Accounts receivable, net 119,711 112,130
Inventories 24,277 23,395
Prepaid assets 15,237 12,354
Assets held for sale 0 10,050
Other current assets 8,077 8,189
Total current assets 605,291 681,508
Property and equipment (net of accumulated depreciation of $131,930 and $109,952, respectively) 102,499 109,465
Operating lease right-of-use assets 96,109 102,197
Intangible assets, net 408,260 442,325
Goodwill 522,766 527,115
Other assets 5,109 7,168
Total non-current assets 1,134,743 1,188,270
Total assets 1,740,034 1,869,778
Current liabilities    
Accounts payable 20,510 17,921
Accrued compensation 40,141 38,304
Accrued expenses and other liabilities 15,070 17,796
Current portion of equipment financing obligations 70 1,135
Current portion of operating lease liabilities 6,584 6,884
Current pharma contract liabilities 7,557 5,192
Total current liabilities 89,932 87,232
Long-term liabilities    
Convertible senior notes, net 535,322 532,483
Operating lease liabilities 68,952 72,289
Deferred income tax liabilities, net 34,750 55,475
Other long-term liabilities 13,055 14,022
Total long-term liabilities 652,079 674,269
Total liabilities 742,011 761,501
Commitments and contingencies (Note 18)
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 126,913,992 and 124,107,500 shares issued and outstanding, respectively) 127 124
Additional paid-in capital 1,160,882 1,123,628
Accumulated other comprehensive loss (3,899) (638)
Accumulated deficit (159,087) (14,837)
Total stockholders’ equity 998,023 1,108,277
Total liabilities and stockholders’ equity $ 1,740,034 $ 1,869,778